Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

New Division of Virology to deliver crucial services for HIV diagnosis and resistance testing
2015-12-14

The establishment of a Division of Virology within the Department of Medical Microbiology, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.  Dr Dominique Goedhals, Head of the Division, says the division will also provide training of undergraduate medical students, medical technologists and technicians, and registrars.

The newly established Division of Virology at the University of the Free State will be one of only five laboratories in the country to be involved in crucial diagnostic and testing services for HIV viral load monitoring, early infant diagnosis, and HIV resistance testing.

The Virology Diagnostic Laboratory serves as the reference laboratory for all HIV National Priority Programme samples for the Free State and Northern Cape provinces.

Medical staff at the laboratory will provide a 24-hour consultative service, as well as outreach programmes to district laboratories in the Free State and Northern Cape where pathologists are not available. 

Dr Dominique Goedhals, Head of the Division of Virology, says this division, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.

The division will not only deliver this critical diagnostic service, but will also focus on training and teaching, as well as research.

Teaching and training activities include teaching of undergraduate medical students, medical technologists and technicians, and registrars.  The postgraduate science programme has a high output of honours, master’s and doctoral students in Virology.  The intern medical scientist programme is also active, with five interns having successfully submitted their portfolios since the programme was implemented in 2010.

Research activities under the Head of Research, Prof Felicity Burt, have also expanded and continue to show increases in publication output and acquisition of grant funding.  Established research groups within the Division of Virology focus on vector-borne and zoonotic viruses, human papilloma viruses (HPV), and human immunodeficiency virus (HIV), as well as work with a number of international collaborators.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept